Search Results

There are 9049 results for: content related to: Treatment of chronic hepatitis B: Case selection and duration of therapy

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. Management of viral hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue s1, February 2002, Pages: S125–S145, CHUTIMA PRAMOOLSINSUP

    Version of Record online : 8 MAY 2002, DOI: 10.1046/j.1440-1746.17.s1.3.x

  3. Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 34–42, Jung Hyun Kwon, Jeong Won Jang, Jong Young Choi, Chung-Hwa Park, Sun Hong Yoo, Si Hyun Bae and Seung Kew Yoon

    Version of Record online : 14 NOV 2012, DOI: 10.1002/jmv.23421

  4. Four years of lamivudine treatment in Chinese patients with chronic hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue 11, November 2004, Pages: 1276–1282, TING-TSUNG CHANG, CHING-LUNG LAI, RONG-NAN CHIEN, RICHARD GUAN, SENG-GEE LIM, CHUAN-MO LEE, KENG-YEEN NG, GRAHAM J NICHOLLS, JULIE C DENT and NANCY WY LEUNG

    Version of Record online : 11 JUN 2004, DOI: 10.1111/j.1440-1746.2004.03428.x

  5. Management of chronic hepatitis B virus infection: a new era of disease control

    Internal Medicine Journal

    Volume 36, Issue 2, February 2006, Pages: 100–113, G. C. Farrell and N. C. Teoh

    Version of Record online : 10 FEB 2006, DOI: 10.1111/j.1445-5994.2006.01027.x

  6. You have free access to this content
    Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy

    Hepatology

    Volume 34, Issue 4, October 2001, Pages: 785–791, Man-Fung Yuen, Erwin Sablon, Prof. Chee-Kin Hui, He-Jun Yuan, Hilde Decraemer and Ching-Lung Lai

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2001.27563

  7. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  8. Stopping lamivudine therapy after biochemical breakthrough may be a feasible option in selected HBeAg-positive patients

    Journal of Medical Virology

    Volume 77, Issue 3, November 2005, Pages: 367–373, Jeong Won Jang, Jong Young Choi, Si Hyun Bae, Seung Kew Yoon, Chang Wook Kim, Soon Woo Nam, Chang Don Lee, Young Sok Lee, Sang Bok Cha and Kyu Won Chung

    Version of Record online : 19 SEP 2005, DOI: 10.1002/jmv.20465

  9. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update

    Liver International

    Volume 25, Issue 3, June 2005, Pages: 472–489, Yun-Fan Liaw, Nancy Leung, Richard Guan, George K.K. Lau, Ismail Merican, Geoff McCaughan, Edward Gane, Jia-Horng Kao, Masao Omata and for the Asian-Pacific consensus update working party on chronic hepatitis B

    Version of Record online : 21 MAY 2005, DOI: 10.1111/j.1478-3231.2005.01134.x

  10. Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients

    Pediatrics International

    Volume 47, Issue 4, August 2005, Pages: 372–377, Yen-Hsuan Ni, Fu-Chen Huang, Tzee-Chung Wu, Man-Shan Kong, Yung-Ming Jeng, Pei-Jer Chen, Daw-Jen Tsuei, Huey-Ling Chen, Hong-Yuan Hsu and Mei-Hwei Chang

    Version of Record online : 29 JUL 2005, DOI: 10.1111/j.1442-200x.2005.02101.x

  11. Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg-positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 4, July 2005, Pages: 393–397, J. W. Shin, N. H. Park, J. H. Park, J. H. Park, I. D. Jeong, S-J. Bang, K. R. Joo and D. H. Kim

    Version of Record online : 14 MAR 2005, DOI: 10.1111/j.1365-2893.2005.00606.x

  12. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Version of Record online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  13. You have free access to this content
    Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy

    Hepatology

    Volume 33, Issue 6, June 2001, Pages: 1527–1532, Nancy W. Y. Leung, Ching-Lung Lai, Ting-Tsung Chang, Richard Guan, Chuan-Mo Lee, Keng-Yeen Ng, Seng-Gee Lim, Pui-Chee Wu, Julie C. Dent, Sally Edmundson, Lynn D. Condreay and Rong-Nan Chien

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2001.25084

  14. You have free access to this content
    Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B

    Hepatology

    Volume 43, Issue 2, February 2006, Pages: 225–232, Etienne M. Sokal, Deirdre A. Kelly, Jacek Mizerski, Isabel B. Badia, Jorge A. Areias, Kathleen B. Schwarz, Angela Vegnente, Nancy R. Little, Stephen D. Gardener and Maureen M. Jonas

    Version of Record online : 26 JAN 2006, DOI: 10.1002/hep.21020

  15. You have free access to this content
    The Cost-Effectiveness of Alternative Therapeutic Strategies for the Management of Chronic Hepatitis B in Poland

    Value in Health

    Volume 5, Issue 5, September 2002, Pages: 405–421, Ewa Orlewska

    Version of Record online : 16 SEP 2002, DOI: 10.1046/j.1524-4733.2002.55147.x

  16. APASL Abstracts, Bali 2005

    Liver International

    Volume 25, Issue 6, December 2005, Pages: 1270–1384,

    Version of Record online : 11 NOV 2005, DOI: 10.1111/j.1478-3231.2005.01182.x

  17. You have free access to this content
    A 7-year study of lamivudine therapy for hepatitis B virus e antigen-positive chronic hepatitis B patients in China

    Journal of Digestive Diseases

    Volume 10, Issue 2, May 2009, Pages: 131–137, Guang Bi YAO, Mei ZHU, Zhen Yu CUI, Bao En WANG, Ji Lu YAO and Ming De ZENG

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1751-2980.2009.00375.x

  18. Changes in serum hepatitis B e antigen (HBeAg) levels associated with the emergence of YMDD mutants in HBeAg non-seroconverted patients during lamivudine therapy

    Liver International

    Volume 27, Issue 10, December 2007, Pages: 1349–1355, Yi-Hao Yen, Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, Chun-Mei Wu, Chao-Hung Hung, Po-lin Tseng, Tsung-Hui Hu, Chi-Sin Changchien and Chuan-Mo Lee

    Version of Record online : 20 NOV 2007, DOI: 10.1111/j.1478-3231.2007.01609.x

  19. Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment

    Hepatology Research

    Volume 40, Issue 2, February 2010, Pages: 125–134, Mariko Kobayashi, Fumitaka Suzuki, Norio Akuta, Hiromi Yatsuji, Tetsuya Hosaka, Hitomi Sezaki, Masahiro Kobayashi, Yusuke Kawamura, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Rie Mineta, Satomi Iwasaki, Sachiyo Watahiki and Hiromitsu Kumada

    Version of Record online : 25 SEP 2009, DOI: 10.1111/j.1872-034X.2009.00565.x

  20. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644